Michael Luu

MathematicsMedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Impact of the Early COVID-19 Pandemic on Incidence and Outcomes of Hepatocellular Carcinoma in the United States

Clinical and Translational Gastroenterology(2024)10.14309/ctg.0000000000000723

Top 19%

1.0DataRank

Top 19%8 citations

Yi‐Te Lee, Yee Hui Yeo, Michael Luu, Walid S. Ayoub, Alexander Kuo +12 more

Papers

Driven by 19 papers — median percentile 81. Top paper: “Impact of the Early COVID-19 Pandemic on Incidence and Outcomes of Hepatocellular Carcinoma in the United States”.

Impact of the Early COVID-19 Pandemic on Incidence and Outcomes of Hepatocellular Carcinoma in the United States

Clinical and Translational Gastroenterology(2024)10.14309/ctg.0000000000000723

Top 19%

1.0DataRank

Top 19%8 citations

Yi‐Te Lee, Yee Hui Yeo, Michael Luu, Walid S. Ayoub, Alexander Kuo +12 more

Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial

JNCI Cancer Spectrum(2025)10.1093/jncics/pkaf032

N/A

0.208DataRank · unranked

3 citations

Sungjin Kim, N. Lynn Henry, Ron D. Hays, Vinícius F. Calsavara, Michael Luu +11 more

Therapeutic Underuse and Delay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and Clinical Impact

Hepatology Communications(2021)10.1002/hep4.1795

N/A

0DataRank · unranked

21 citations

Michael Luu, Marie Lauzon, Kambiz Kosari, Joseph Ahn, Nicole E. Rich +5 more

Visualizing adverse events in clinical trials using correspondence analysis with R-package visae

BMC Medical Research Methodology(2021)10.1186/s12874-021-01368-w

N/A

0DataRank · unranked

0 citations

Gillian Gresham, Sungjin Kim, Michael Luu, N. Lynn Henry, Mourad Tighiouart +4 more

Disparities in curative treatments and outcomes for early stage intrahepatic cholangiocarcinoma in the United States

Cancer(2022)10.1002/cncr.34436

N/A

0DataRank · unranked

15 citations

Amit G. Singal, Marie Lauzon, Vatche G. Agopian, Michael Luu, Mazen Noureddin +10 more

Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30

npj Breast Cancer(2022)10.1038/s41523-022-00489-9

N/A

0DataRank · unranked

9 citations

Sungjin Kim, Ron D. Hays, Márcio A. Diniz, Mourad Tighiouart, Gillian Gresham +6 more

Increasing Incidence of Intrahepatic Cholangiocarcinoma Relative to Hepatocellular Carcinoma in the United States

Gastro Hep Advances(2022)10.1016/j.gastha.2021.10.010

N/A

0DataRank · unranked

7 citations

Amit G. Singal, Michael Luu, N. Nissen, Gregory J. Gores, Ju Dong Yang +1 more

COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States

Gastro Hep Advances(2023)10.1016/j.gastha.2023.11.011

N/A

0DataRank · unranked

6 citations

Yee Hui Yeo, Jeff Liang, Michael Luu, Walid S. Ayoub, Alexander Kuo +11 more

Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial

Cancer Prevention Research(2023)10.1158/1940-6207.capr-23-0216

N/A

0DataRank · unranked

4 citations

N. Lynn Henry, Ron D. Hays, Sungjin Kim, Michael Luu, Márcio A. Diniz +7 more

Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.02.010

N/A

0DataRank · unranked

7 citations

Michael Luu, Martha K. Terris, Zachary Klaassen, Christopher J. Kane, Christopher L. Amling +6 more

Variation in content discussed by specialty in consultations for clinically localized prostate cancer

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.04.012

N/A

0DataRank · unranked

2 citations

Michael Luu, Rebecca Gale, Antwon Chaplin, Leslie K. Ballas, Howard M. Sandler +6 more

Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501/EORTC 22931

Annals of Oncology(2025)10.1016/j.annonc.2025.07.004

N/A

0DataRank · unranked

10 citations

Michael Luu, Catherine Fortpied, Jong Keon Jang, Meimei Chen, Jon Mallen‐St. Clair +12 more

Development and validation of a natural language processing system to assess quality of physician communication in prostate cancer consultations

Prostate Cancer and Prostatic Diseases(2025)10.1038/s41391-025-01011-5

N/A

0DataRank · unranked

4 citations

Nadine A. Friedrich, Michael Luu, Rebecca Gale, Dmitry Khodyakov, Stephen J. Freedland +3 more

Analyses of adverse events and patient‐reported outcomes with the toxicity index in cancer clinical trials

Cancer(2025)10.1002/cncr.70086

N/A

0DataRank · unranked

1 citations

N. Lynn Henry, Hanna Bandos, Vinícius F. Calsavara, Reena S. Cecchini, Márcio A. Diniz +8 more

Topic Mapping to Inform Content to Discuss in Shared Decision-Making for Prostate Cancer

Urology(2025)10.1016/j.urology.2025.05.053

N/A

0DataRank · unranked

0 citations

Paul Kokorowski, Michael Luu, Antwon Chaplin, Reva Polineni, Alex Shiang +6 more

Scoring Physician Risk Communication in Prostate Cancer Using Large Language Models

medRxiv(2025)10.1101/2025.08.07.25333034

N/A

0DataRank · unranked

0 citations

Dongfang Xu, Michael Luu, Renning Zheng, Timothy J. Daskivich, Graciela Gonzalez‐Hernandez +1 more

Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa028

N/A

0DataRank · unranked

40 citations

Márcio A. Diniz, Zahra S. Razaee, Michael Luu, Sungjin Kim, Ron D. Hays +6 more

Are Urologists and/or Radiation Oncologists Biased when Reporting of Advantages and Disadvantages of Surgery versus Radiation in Consultations for Early-Stage Prostate Cancer?

Clinical Genitourinary Cancer(2025)10.1016/j.clgc.2025.102486

N/A

0DataRank · unranked

0 citations

Michael Luu, Rebecca Gale, Antwon Chaplin, Reva Polineni, Alex Shiang +7 more

The Mortality and Overall Survival Trends of Primary Liver Cancer in the United States

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab079

N/A

0DataRank · unranked

109 citations

Jasmine J. Wang, Michael Luu, Mazen Noureddin, Kambiz Kosari, Vatche G. Agopian +7 more

Michael Luu

Indexed papers

Top data-sharing exemplar

Papers